Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Ozagrel Sodium Injection
- Product Name
- 奥扎格雷钠注射液
- Approval Number
- 国药准字H20193226
- Approval Date
- May 21, 2024
NMPA
Ozagrel Sodium Injection
- Product Name
- 奥扎格雷钠注射液
- Approval Number
- 国药准字H20193227
- Approval Date
- May 21, 2024
NMPA
Ganciclovir for Injection
- Product Name
- 注射用更昔洛韦
- Approval Number
- 国药准字H20058061
- Approval Date
- Jul 10, 2020
NMPA
Recombinant Human Interferon α2b for Injection
- Product Name
- 莱福隆
- Approval Number
- 国药准字S19990025
- Approval Date
- Jul 10, 2020
NMPA
Recombinant Human Interferon α2b for Injection
- Product Name
- 莱福隆
- Approval Number
- 国药准字S20063024
- Approval Date
- Jul 10, 2020
NMPA
Recombinant Human Interferon α2b for Injection
- Product Name
- 莱福隆
- Approval Number
- 国药准字S19990024
- Approval Date
- Jul 10, 2020
NMPA
Moroxydine Hydrochloride Tablets
- Product Name
- 盐酸吗啉胍片
- Approval Number
- 国药准字H22024461
- Approval Date
- May 25, 2020
NMPA
Compound Aminopyrine Phenacetin Tablets
- Product Name
- 去痛片
- Approval Number
- 国药准字H22020815
- Approval Date
- May 4, 2016
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found